tiprankstipranks
Trending News
More News >

China Tian Yuan Healthcare Reports Increased Losses in 2024 Financial Results

Story Highlights
  • China Tian Yuan Healthcare operates in the healthcare industry, providing medical services.
  • The company reported a significant revenue decline and increased losses for 2024.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
China Tian Yuan Healthcare Reports Increased Losses in 2024 Financial Results

Don’t Miss TipRanks’ Half-Year Sale

China Tian Yuan Healthcare Group Limited ( (HK:0557) ) just unveiled an announcement.

China Tian Yuan Healthcare Group Limited reported its audited consolidated financial results for the year ending December 31, 2024, revealing a significant decline in revenue from HK$45,230,000 in 2023 to HK$26,845,000 in 2024. The company experienced a loss attributable to equity shareholders of HK$34,238,000, compared to a loss of HK$15,484,000 in the previous year, indicating financial challenges that may impact its market position and stakeholder confidence.

More about China Tian Yuan Healthcare Group Limited

China Tian Yuan Healthcare Group Limited operates in the healthcare industry, focusing on providing medical and healthcare services. The company is incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange.

YTD Price Performance: -14.42%

Average Trading Volume: 15,472

Technical Sentiment Signal: Buy

Current Market Cap: HK$177.5M

See more insights into 0557 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1